Clinical Trials
7
Active:4
Completed:2
Trial Phases
4 Phases
Phase 1:3
Phase 2:2
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (42.9%)Phase 2
2 (28.6%)Not Applicable
1 (14.3%)Phase 4
1 (14.3%)Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer During Chemotherapy in Combination With HER2-targeted Therapy or Antibody-drug Conjugate Therapy.
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Palleos Healthcare GmbH
- Target Recruit Count
- 585
- Registration Number
- NCT05425550
- Locations
- 🇨🇭
Seespital Horgen-Onkologie, Horgen, Switzerland
Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy
Phase 2
Completed
- Conditions
- Triple-negative Breast Cancer
- Interventions
- Procedure: Biopsy Arm BProcedure: Biopsy Arm AProcedure: Surgery
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Palleos Healthcare GmbH
- Target Recruit Count
- 416
- Registration Number
- NCT04770272
- Locations
- 🇩🇪
Marienhospital Bottrop gGmbH; Klinik für Frauenheilkunde und Geburtshilfe;, Bottrop, Germany
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
Phase 2
Completed
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Palleos Healthcare GmbH
- Target Recruit Count
- 257
- Registration Number
- NCT03272477
- Locations
- 🇩🇪
Evangelisches Krankenhaus Bethesda Mönchengladbach, Mönchengladbach, Germany
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
Phase 4
Terminated
- Conditions
- Breast Neoplasm
- Interventions
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Palleos Healthcare GmbH
- Target Recruit Count
- 532
- Registration Number
- NCT03220178
- Locations
- 🇩🇪
University Hospital Mainz, Mainz, Germany
News
No news found